Javascript must be enabled to continue!
Faecal Microbiota Transplantation (FMT) in Veterinary Medicine: A Mini Review
View through CrossRef
Faecal microbiota transplantation (FMT) is a therapeutic approach that involves the transfer of faecal microbiota from a healthy donor to a recipient, aiming to restore a balanced microbial community in the recipient’s gut. FMT has achieved significant success in human medicine, particularly in the treatment of Clostridioides difficile infection (CDI) and other gastrointestinal disorders. While FMT has been utilised in veterinary medicine for decades, its formal recognition in human medicine has influenced its adoption and advancement. In this mini review article, we provide a concise analysis of the mechanisms underlying FMT and trace the historical development of transplantation procedures in veterinary medicine. We explore the current applications of FMT in companion animals and livestock, highlighting its efficacy in managing gastrointestinal disorders. Additionally, we discuss the synergistic role of metagenomics, metabolomics, and artificial intelligence (AI) in shaping modern FMT practice, emphasizing their potential for improving FMT efficacy, personalized treatment strategies, and diagnostic approaches in veterinary medicine. By reviewing pertinent scientific literature, this comprehensive review explores the historical perspective, current state, and potential impact of FMT in the field of veterinary medicine.
Kerala Veterinary and Animal Sciences University
Title: Faecal Microbiota Transplantation (FMT) in Veterinary Medicine: A Mini Review
Description:
Faecal microbiota transplantation (FMT) is a therapeutic approach that involves the transfer of faecal microbiota from a healthy donor to a recipient, aiming to restore a balanced microbial community in the recipient’s gut.
FMT has achieved significant success in human medicine, particularly in the treatment of Clostridioides difficile infection (CDI) and other gastrointestinal disorders.
While FMT has been utilised in veterinary medicine for decades, its formal recognition in human medicine has influenced its adoption and advancement.
In this mini review article, we provide a concise analysis of the mechanisms underlying FMT and trace the historical development of transplantation procedures in veterinary medicine.
We explore the current applications of FMT in companion animals and livestock, highlighting its efficacy in managing gastrointestinal disorders.
Additionally, we discuss the synergistic role of metagenomics, metabolomics, and artificial intelligence (AI) in shaping modern FMT practice, emphasizing their potential for improving FMT efficacy, personalized treatment strategies, and diagnostic approaches in veterinary medicine.
By reviewing pertinent scientific literature, this comprehensive review explores the historical perspective, current state, and potential impact of FMT in the field of veterinary medicine.
Related Results
Faecal Microbiota Transplantation from Patients with Depression Into Rats Modulates Mood-Related Behaviour
Faecal Microbiota Transplantation from Patients with Depression Into Rats Modulates Mood-Related Behaviour
Abstract
Differences in gut microbiota composition have been observed in patients with major depressive disorder (MDD) compared to healthy individuals. Here, we investigate...
Patients’ views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?
Patients’ views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?
Background
Fecal microbiota transplantation (FMT) represents a new therapeutic option that has been studied in two randomized-controlled trials in ulcerative colitis pa...
Low acceptance of illness with inflammatory bowel disease tending to receive fecal microbiota transplantation
Low acceptance of illness with inflammatory bowel disease tending to receive fecal microbiota transplantation
Abstract
Background
Fecal microbiota transplantation(FMT) can improve and reestablish the normal function of intestinal flora. It has been shown to have great potential in...
Oral Corticosteroids Impair Mucin Production and Alter the Posttransplantation Microbiota in the Gut
Oral Corticosteroids Impair Mucin Production and Alter the Posttransplantation Microbiota in the Gut
<b><i>Introduction:</i></b> Gut microbiota alterations cause inflammation in patients with ulcerative colitis (UC). Fecal microbiota transplantation (FMT) e...
Effects and Microbiota Changes Following Oral Lyophilized Fecal Microbiota Transplantation Capsules in Canine with Chronic Enteropathy After Parvovirus Infection: Case Report
Effects and Microbiota Changes Following Oral Lyophilized Fecal Microbiota Transplantation Capsules in Canine with Chronic Enteropathy After Parvovirus Infection: Case Report
(1) Background: Chronic enteropathy (CE) in canines is associated with persistent microbiome dysbiosis, and conventional therapies (e.g., special diets, antimicrobials, and immunos...
289 Evaluation of fecal microbiota transplantation in primiparous sows
289 Evaluation of fecal microbiota transplantation in primiparous sows
Abstract
Fifty primiparous (parity 3+) and 25 multiparous sows (DNA 241, DNA, Columbus, NE) were used to evaluate the impacts of fecal microbiota transplantation (FM...
Fecal microbiota from MRL/Lpr mice exacerbates pristane induced lupus
Fecal microbiota from MRL/Lpr mice exacerbates pristane induced lupus
Abstract
Background: The roles of gut microbiota in the pathogenesis of SLE have been receiving much attention during recent years. However, it still remains unknown how fe...
FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder
FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder
IntroductionAutism spectrum disorder (ASD) is a complicated diffuse developmental disorder that commonly involves gastrointestinal distress and dysbacteriosis. Emerging lines of ev...

